NCT02634515 - Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Diabetes Mellitus

Interventions

DRUG

Julphar Insulin R (soluble human insulin, biosimilar)

investigational insulin, Julphar Insulin R (soluble human insulin)

DRUG

Huminsulin® Normal (soluble human insulin, reference)

marketed product, Huminsulin® Normal (soluble human insulin

Trial Locations (1)

Profil Institut für Stoffwechselforschung GmbH, Neuss